- Invicta Diagnostic began commercial operations at its Dadar centre from 30th January 2026, offering advanced and routine diagnostics including PET-CT, CT, Sonography, Pathology and X-Ray with proximity to Tata Memorial Hospital expected to support oncology-led volumes.
- Cupid CMD Aditya Kumar Halwasiya acquired 6,46,513 shares via market purchases, raising his stake to 32.82% and promoter group holding to 45.80%, reflecting strong promoter confidence in long-term growth.
- Ducon Infratechnologies is emerging as an early mover in India’s CCUS space, having initiated solvent-based carbon capture R&D ahead of the Union Budget 2026’s Rs.20,000 cr. push, aligning with mandatory decarbonisation opportunities.
- Khazanchi Jewellers will be inaugurating its flagship showroom at Chennai on 7th February 2026.
- Alpa Laboratories trades at an attractive PE of 7.93x vs. the pharma industry average of 29.37x, offering scope for ~80% upside over the long term.
